NANOFS.ST
HoldHot AirNanoform Finland Oyj · Healthcare · Finland · $77M · Avg Vol: $9K/d
Hot Air: Rising on momentum alone: weak business, rich price.
ABOUT NANOFORM FINLAND OYJ
Read
Nanoform Finland Oyj is an innovative nanoparticle medicine-enabling company specializing in improving the clinical performance of pharmaceutical ingredients. Utilizing its proprietary Controlled Expansion of Supercritical Solutions (CESS) technology, the company reduces drug particle sizes to the nanometer scale to enhance solubility and bioavailability. Nanoform operates as a high-margin technology partner for global pharma, protected by a robust patent portfolio.
FINANCIAL SUMMARY (SEK)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 39.4M | 29.0M | 31.4M | 40.1M | 0.6% | 62.9M | 58.8M | 93.2M | 52.5% |
| EPS (SEK) | -3.28 | -2.94 | -3.16 | -2.37 | — | -1.82 | — | — | — |
| Shares | 78.4M | 78.4M | 85.5M | 85.7M | +9.3% | 85.8M | — | — | — |
| Debt | 78.3M | 70.7M | 62.8M | 70.2M | -3.6% | 73.1M | — | — | — |
| Equity | 985.4M | 756.4M | 678.3M | 483.3M | -21.1% | — | — | — | — |
| Op CF | -226.9M | -203.4M | -206.5M | -199.6M | — | -153.3M | — | — | — |
| Inv CF | -108.7M | -400.8M | 310.1M | 57.5M | — | — | — | — | — |
| Fin CF | 256.9M | -13.5M | 154.1M | 1.4M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of NANOFS.ST are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| NANOFS.ST | Nanoform Finland Oyj(you) | $77M | 37 | Hold |
| FARN.L | Faron Pharmaceuticals Oy | $95M | 7 | Strong Sell |
| HRTIS.HE | Herantis Pharma Oyj | $51M | 5 | Strong Sell |
| NXTMH.HE | Nexstim Plc | $79M | 27 | Sell |
| MODU.HE | Modulight Oyj | $51M | 32 | Sell |
| OPTOMED.HE | Optomed Oyj | $59M | 16 | Strong Sell |
| HEALTH.HE | Nightingale Health Oyj | $65M | 13 | Strong Sell |
| AIFORIA.HE | Aiforia Technologies Oyj | $74M | 3 | Strong Sell |
| REG1V.HE | Revenio Group Oyj | $435M | 44 | Hold |
| ORIOLA.HE | Oriola Oyj | $191M | 67 | Buy |
Peer medians: ROE -4.3% · P/E 19.5x · Gross margin 65.9%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.